Drug interactions between cilastatin / imipenem and Duration
| Results for the following 2 drugs: |
|---|
| cilastatin/imipenem |
| Duration (oxymetazoline nasal) |
Interactions between your drugs
There were no interactions found in our database between cilastatin / imipenem and Duration - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
cilastatin / imipenem
A total of 78 drugs are known to interact with cilastatin / imipenem.
- Cilastatin / imipenem is in the drug class carbapenems.
- Cilastatin / imipenem is used to treat the following conditions:
- Aspiration Pneumonia
- Bacteremia
- Bacterial Infection
- Bone infection
- Bronchitis
- Deep Neck Infection
- Endocarditis
- Endometritis
- Febrile Neutropenia
- Intraabdominal Infection
- Joint Infection
- Kidney Infections
- Lemierre's Syndrome
- Meningitis
- Nosocomial Pneumonia
- Pelvic Infections
- Peritonitis
- Pneumonia
- Pneumonia with Cystic Fibrosis
- Septicemia
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- Urinary Tract Infection
Duration
A total of 75 drugs are known to interact with Duration.
- Duration is a member of the drug class nasal antihistamines and decongestants.
- Duration is used to treat Nasal Congestion.
Drug and food interactions
No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
